000 01219 a2200373 4500
005 20250518025918.0
264 0 _c20200220
008 202002s 0 0 eng d
022 _a1718-7729
024 7 _a10.3747/co.26.4203
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYang, Y
245 0 0 _aEfficacy and safety of combined androgen blockade with antiandrogen for advanced prostate cancer.
_h[electronic resource]
260 _bCurrent oncology (Toronto, Ont.)
_c02 2019
300 _ae39-e47 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
650 0 4 _aAndrogen Antagonists
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProgression-Free Survival
650 0 4 _aProstatic Neoplasms
_xdrug therapy
700 1 _aChen, R
700 1 _aSun, T
700 1 _aZhao, L
700 1 _aLiu, F
700 1 _aRen, S
700 1 _aWang, H
700 1 _aLu, X
700 1 _aGao, X
700 1 _aXu, C
700 1 _aSun, Y
773 0 _tCurrent oncology (Toronto, Ont.)
_gvol. 26
_gno. 1
_gp. e39-e47
856 4 0 _uhttps://doi.org/10.3747/co.26.4203
_zAvailable from publisher's website
999 _c29460407
_d29460407